China Resources Boya Bio pharmaceutical Group Co Ltd

Boya Bio-pharmaceutical announced on the evening of October 8 that its board of directors received a written resignation report from Chairman Qiu Kai that day. Due to work adjustments, Qiu Kai applied to resign as chairman of the eighth board of directors and as a non-independent director, and also resigned as chairman of the board's Strategy and ESG Committee and as a member of the Nomination, Compensation and Assessment Committee. After his resignation, he will no longer hold any position in the company, and the resignation report took effect on the same day after the conclusion of the board meeting. On the same day, Boya Bio-pharmaceutical held the twenty-third meeting of the eighth board of directors and agreed to nominate Li Ning as a candidate for non-independent director of the eighth board of directors. The announcement shows that Li Ning previously served as deputy general manager of the marketing management center of China Resources Double-Crane Pharmaceutical, head of the market access department of the operating company, general manager of the Beijing business division, and director of the operating company's business division. He currently serves as vice president of China Resources Pharmaceutical Group and chairman of China Resources Biopharmaceutical.